A prospective randomized controlled trial of utility of antibiotic prophylaxis in patients after liver resection

A prospective randomized controlled trial of utility of antibiotic prophylaxis in patients after liver resection - Evaluation of antibiotic prophylaxis after liver resection

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002187

Enrollment

100

Registered

2009-07-13

Start date

2009-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma, metastatic liver tumor, cholangiocarcinoma, liver tumor, biliary cancer, biliary tumor

Interventions

Administration of prophylactic antibiotic after liver resection Non-administration of prophylactic antibiotic after liver resection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with hepato-biliary disease who were performed hepatectomy at Osaka Medical college Hospital

Exclusion criteria

Exclusion criteria: 1) patients with severe complications which were possible to prolong hospital stay, 2) patients undergone hemodialysis, 3) patients combined resection of other organs, 4) patients who were diagnosed inadequacy for this study by a physician, and 5) patients without an informed consent

Design outcomes

Primary

Measure	Time frame
septic complications (wound infection, infectious ascites, abdominal abscess, pneumonia, urinary infection, catheter infection)	—

Secondary

Measure	Time frame
the incidence of other postoperative complications, mortality,bile leakage, ascites, abdominal hemorrhage.	—

Countries

Japan

Contacts

Public ContactFumitoshi hirokawa

Osaka Medical College Department of General and Gastroenterological Surgery

sur122@poh.osaka-med.ac.jp072-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026